Increased risk of multiple myeloma, B-cell neoplasms, and cancer in general

A number of studies with lowish p-values but low heterogeneity across studies show a reduced risk of multiple myeloma, greater in homozygotes, for the A allele. There is also a generalized reduction in cancer risk. B-cell neoplasms may be particularly affected.